CTT Pharmaceuticals Holdings, Inc. Announces Uplisting to OTCQB Market Trading
CTT Pharmaceutical Holdings (OTCQB:CTTH) has received approval from OTC Markets Group for uplisting its common shares to the OTCQB Market, effective March 10, 2025. The company will continue trading under the symbol 'CTTH'.
The uplisting to OTCQB, a premier marketplace for early-stage pharmaceutical companies developing new technology, is expected to enhance trading liquidity and provide a more streamlined trading experience for U.S. shareholders. Companies listed on OTCQB must maintain current reporting status and undergo annual PCAOB audits.
The company plans to make formal announcements regarding the uplisting on March 10, 2025, followed by a CEO news release to shareholders on March 12, 2025.
CTT Pharmaceutical Holdings (OTCQB:CTTH) ha ricevuto l'approvazione dal OTC Markets Group per il passaggio delle sue azioni ordinarie al Mercato OTCQB, a partire dal 10 marzo 2025. L'azienda continuerà a essere quotata con il simbolo 'CTTH'.
Il passaggio all'OTCQB, un mercato di riferimento per le aziende farmaceutiche in fase iniziale che sviluppano nuove tecnologie, dovrebbe migliorare la liquidità degli scambi e offrire un'esperienza di trading più fluida per gli azionisti statunitensi. Le aziende quotate sull'OTCQB devono mantenere uno stato di reporting attuale e sottoporsi a verifiche annuali da parte del PCAOB.
L'azienda prevede di fare annunci formali riguardo al passaggio il 10 marzo 2025, seguito da un comunicato stampa del CEO agli azionisti il 12 marzo 2025.
CTT Pharmaceutical Holdings (OTCQB:CTTH) ha recibido la aprobación del OTC Markets Group para la inclusión de sus acciones comunes en el Mercado OTCQB, que será efectiva el 10 de marzo de 2025. La compañía continuará cotizando bajo el símbolo 'CTTH'.
La inclusión en OTCQB, un mercado de prestigio para empresas farmacéuticas en etapas tempranas que desarrollan nuevas tecnologías, se espera que mejore la liquidez del comercio y proporcione una experiencia de negociación más fluida para los accionistas estadounidenses. Las empresas que cotizan en OTCQB deben mantener su estado de reporte actual y someterse a auditorías anuales por parte del PCAOB.
La compañía planea hacer anuncios formales sobre la inclusión el 10 de marzo de 2025, seguido de un comunicado de prensa del CEO a los accionistas el 12 de marzo de 2025.
CTT Pharmaceutical Holdings (OTCQB:CTTH)는 OTC Markets Group으로부터 일반 주식을 OTCQB 시장으로 상장하기 위한 승인을 받았으며, 이는 2025년 3월 10일부터 시행됩니다. 회사는 'CTTH' 기호로 계속 거래됩니다.
OTCQB로의 상장은 새로운 기술을 개발하는 초기 단계의 제약 회사들을 위한 주요 시장으로, 거래 유동성을 향상시키고 미국 주주들에게 보다 원활한 거래 경험을 제공할 것으로 예상됩니다. OTCQB에 상장된 회사는 현재 보고 상태를 유지하고 PCAOB의 연간 감사에 통과해야 합니다.
회사는 2025년 3월 10일에 상장에 대한 공식 발표를 할 계획이며, 2025년 3월 12일에는 CEO의 주주를 위한 뉴스 릴리스를 발표할 예정입니다.
CTT Pharmaceutical Holdings (OTCQB:CTTH) a reçu l'approbation du OTC Markets Group pour le transfert de ses actions ordinaires au Marché OTCQB, effectif le 10 mars 2025. L'entreprise continuera à être cotée sous le symbole 'CTTH'.
Le transfert vers l'OTCQB, un marché de premier plan pour les entreprises pharmaceutiques en phase de démarrage développant de nouvelles technologies, devrait améliorer la liquidité des échanges et offrir une expérience de trading plus fluide pour les actionnaires américains. Les entreprises cotées sur l'OTCQB doivent maintenir un statut de reporting actuel et subir des audits annuels par le PCAOB.
L'entreprise prévoit de faire des annonces officielles concernant le transfert le 10 mars 2025, suivies d'un communiqué de presse du PDG aux actionnaires le 12 mars 2025.
CTT Pharmaceutical Holdings (OTCQB:CTTH) hat die Genehmigung von OTC Markets Group für die Listung ihrer Stammaktien im OTCQB-Markt erhalten, die am 10. März 2025 wirksam wird. Das Unternehmen wird weiterhin unter dem Symbol 'CTTH' gehandelt.
Die Listung im OTCQB, einem erstklassigen Marktplatz für aufstrebende Pharmaunternehmen, die neue Technologien entwickeln, wird voraussichtlich die Handelsliquidität verbessern und den Aktionären in den USA ein reibungsloseres Handelserlebnis bieten. Unternehmen, die im OTCQB gelistet sind, müssen den aktuellen Berichtstatus aufrechterhalten und sich jährlichen PCAOB-Prüfungen unterziehen.
Das Unternehmen plant, am 10. März 2025 formelle Ankündigungen zur Listung zu machen, gefolgt von einer Pressemitteilung des CEO an die Aktionäre am 12. März 2025.
- Uplisting to OTCQB Market approved
- Expected increase in trading liquidity
- Enhanced visibility for U.S. investors
- None.
TAMPA, FL / ACCESS Newswire / March 5, 2025 / CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) is pleased to announce the OTC Markets Group has approved the trading of its common shares on the OTCQB Market. The company's common shares will trade on the OTCQB under the symbol "CTTH" as of the opening of the market on March 10, 2025. Uplisting to the OTCQB should provide CTT with greater liquidity and a more seamless trading experience for U.S. shareholders. The OTCQB is a premier marketplace for Pharmaceutical companies in early stage that are moving towards development of new technology. Companies listed on the OTCQB are current in their reporting and undergo yearly PCAOB Audits. CTT will make a formal announcement on March 10, 2025 announcing the uplisting to the OTCQB investor community. The CEO of CTT Pharma will issue a news release to shareholders on March 12, 2025.
CTT Pharma - 813-606-0060
SOURCE: CTT Pharmaceutical Holdings, Inc.
View the original press release on ACCESS Newswire
FAQ
When will CTT Pharmaceutical Holdings (CTTH) begin trading on the OTCQB Market?
What are the benefits of CTTH's uplisting to OTCQB Market?
What requirements must CTTH meet to maintain OTCQB listing?
When will CTTH's CEO release news about the uplisting to shareholders?
